Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biotricity Inc BTCY

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s... see more

Recent & Breaking News (OTCQB:BTCY)

New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products

Accesswire April 21, 2023

Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead

Accesswire April 19, 2023

Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report

Accesswire April 11, 2023

Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation

Accesswire March 7, 2023

Biotricity Reports Financial Results for Fiscal 2023 Third Quarter

Accesswire February 14, 2023

Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET

Accesswire February 9, 2023

Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference

Accesswire February 3, 2023

Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions

Accesswire January 26, 2023

Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET

Accesswire January 23, 2023

Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023

Accesswire January 17, 2023

Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

Accesswire December 12, 2022

Biotricity Surpasses $10 Million in Annual Revenue Run Rate

Accesswire November 21, 2022

Biotricity Provides Updates on its Operational and Expansion Strategy

Accesswire November 18, 2022

Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions

Accesswire November 16, 2022

Biotricity Reports Financial Results for Fiscal 2023 Second Quarter

Accesswire November 14, 2022

Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022

Accesswire November 10, 2022

Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET

Accesswire November 1, 2022

Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics

Accesswire October 26, 2022

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire October 18, 2022

Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th

Accesswire October 13, 2022